ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1953

The Progression of Cartilage Damage in Rheumatoid Arthritis: A Three Year Prospective 3T- Magnetic Resonance Imaging Study Examining Predictive Factors

Fiona M. McQueen1, Alexandra McHaffie2, Andrew Clarke2, Arier Lee3, Quentin Reeves2, Barbara Curteis1 and Nicola Dalbeth4, 1Molecular Medicine and Pathology, University of Auckland, Auckland, New Zealand, 2Radiology, Auckland District Health Board, Auckland, New Zealand, 3Biostatistics and Epidemiology, University of Auckland, Auckland, New Zealand, 4Auckland District Health Board, Auckland, New Zealand

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: Bone, cartilage and magnetic resonance imaging (MRI)

  • Tweet
  • Email
  • Print
Session Information

Title: Imaging in Rheumatoid Arthritis

Session Type: Abstract Submissions (ACR)

Background/Purpose: Cartilage damage impacts on patient disability in RA. The aims of this MRI study were to investigate cartilage damage over 3 years and determine predictive factors.

Methods: 38 RA patients and 22 controls were enrolled at t=0 (2009). After 3 years, clinical and MRI data were available in 28 patients and 15 controls. 3T MRI scans were scored for cartilage damage, bone erosion, synovitis and osteitis. A model was developed to predict cartilage damage from baseline parameters.

Results : Inter-reader reliability for the Auckland MRI cartilage score (AMRICS) (1) was high for status scores (ICC 0.90 [0.81-0.95]) and moderate for change scores (ICC 0.58 [0.24-0.77]). AMRICS scores were highly correlated with the OMERACT MRI joint space narrowing (jsn) and XR jsn scores (r =0.96, p<0.0001 and 0.80, p<0.0001 respectively). AMRICS change scores were greater for RA patients than controls (p = 0.06 and p = 0.04 for the 2 readers) (Figure 1). Using linear regression, the baseline MRI cartilage score was the strongest predictor of the 3 year MRI cartilage score but synovitis and osteitis scores were also predictive (R2 = 0.67, 0.37 and 0.39 respectively).  Baseline radial osteitis predicted increased cartilage scores at the radiolunate and radioscaphoid joints, (p = 0.0001 and 0.0012 respectively) and synovitis at radioulnar, radiocarpal and intercarpal-carpometacarpal joints also influenced 3 year cartilage scores (p values of 0.001, 0.04 and 0.01 respectively). Using multiple linear regression with outcome of cartilage damage at 3 years the optimal model predicted 76% of the variance of the 3-year AMRICS (R2 = 0.76), the strongest component being the baseline cartilage score (R2 = 0.67). The baseline MRI erosion score was also predictive but to a lesser degree (R2 = 0.47). When the outcome of bone erosion score was used, the strongest predictor was baseline erosion score (R2 = 0.87, p < 0.0001), while baseline cartilage score was less predictive (R2 = 0.49, p = 0.01). These data would support the hypothesis that some patients favour one damage pathway over the other so that those who develop erosions tend to erode further (E-progressors) while those who damage cartilage continue preferentially in that manner (C-progressors) (Figure 2).

Conclusion : MRI cartilage damage progression is preceded by osteitis and synovitis but is most influenced by pre-existing cartilage damage suggesting primacy of the cartilage damage pathway in certain patients.

1)      McQueen FM et al. Ann Rheum Dis 2010;69:1971-75.

 ADDIN EN.REFLIST


Disclosure:

F. M. McQueen,
None;

A. McHaffie,
None;

A. Clarke,
None;

A. Lee,
None;

Q. Reeves,

Specialist Radiology and MRI,

3;

B. Curteis,
None;

N. Dalbeth,
None.

  • Tweet
  • Email
  • Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-progression-of-cartilage-damage-in-rheumatoid-arthritis-a-three-year-prospective-3t-magnetic-resonance-imaging-study-examining-predictive-factors/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology